Sfoglia per Corso
Mostrati risultati da 1 a 7 di 7
Discovery and validation of novel biomarkers for diagnosis and outcome of autoimmune diseases: anti-LIN28A IgG and IgA antibodies are highly specific for Systemic Lupus Erythematosus and are associated with histological activity and treatment response in Lupus Nephritis.
2022/2023 CRUCIANI, CLAUDIO
Effectiveness and safety of rituximab in patients with refractory idiopathic inflammatory myopathies: a retrospective study from a single-center cohort with a special focus on low-dose as a maintenance treatment for remission.
2022/2023 GAMBA, ANNA
Efficacy and safety of Extended-Interval Rituximab vs. Standard MAINRITSAN Regimen for remission Maintenance in ANCA-Associated Vasculitis: A Multicenter Study
2021/2022 CAMPANIELLO, DEBORA
Efficacy of belimumab in SLE with hematological manifestations: retrospective analysis from the BeRLiSS-JS cohort
2022/2023 ARRU, FEDERICO
EVALUATION OF GLUCOCORTICOID WITHDRAWAL DURING REMISSION IN SYSTEMIC LUPUS ERYTHEMATOSUS
2022/2023 VESENTINI, FILIPPO
Synovial Markers in Refractory Rheumatoid Arthritis: Distinguishing Non-Inflammatory and Persistent Inflammatory Phenotypes
2022/2023 SALVATO, MARIANGELA
Unveiling the Unseen Signals: Identifying Novel Diagnostic and Prognostic Biomarkers for Eosinophilic Granulomatosis with Polyangiitis
2022/2023 IORIO, LUCA
Tipologia | Anno | Titolo | Titolo inglese | Autore | File |
---|---|---|---|---|---|
Scuole di Specializzazione | 2022 | Discovery and validation of novel biomarkers for diagnosis and outcome of autoimmune diseases: anti-LIN28A IgG and IgA antibodies are highly specific for Systemic Lupus Erythematosus and are associated with histological activity and treatment response in Lupus Nephritis. | Discovery and validation of novel biomarkers for diagnosis and outcome of autoimmune diseases: anti-LIN28A IgG and IgA antibodies are highly specific for Systemic Lupus Erythematosus and are associated with histological activity and treatment response in Lupus Nephritis. | CRUCIANI, CLAUDIO | |
Scuole di Specializzazione | 2022 | Effectiveness and safety of rituximab in patients with refractory idiopathic inflammatory myopathies: a retrospective study from a single-center cohort with a special focus on low-dose as a maintenance treatment for remission. | Effectiveness and safety of rituximab in patients with refractory idiopathic inflammatory myopathies: a retrospective study from a single-center cohort with a special focus on low-dose as a maintenance treatment for remission. | GAMBA, ANNA | |
Scuole di Specializzazione | 2021 | Efficacy and safety of Extended-Interval Rituximab vs. Standard MAINRITSAN Regimen for remission Maintenance in ANCA-Associated Vasculitis: A Multicenter Study | Efficacy and safety of Extended-Interval Rituximab vs. Standard MAINRITSAN Regimen for remission Maintenance in ANCA-Associated Vasculitis: A Multicenter Study | CAMPANIELLO, DEBORA | |
Scuole di Specializzazione | 2022 | Efficacy of belimumab in SLE with hematological manifestations: retrospective analysis from the BeRLiSS-JS cohort | Efficacy of belimumab in SLE with hematological manifestations: retrospective analysis from the BeRLiSS-JS cohort | ARRU, FEDERICO | |
Scuole di Specializzazione | 2022 | EVALUATION OF GLUCOCORTICOID WITHDRAWAL DURING REMISSION IN SYSTEMIC LUPUS ERYTHEMATOSUS | EVALUATION OF GLUCOCORTICOID WITHDRAWAL DURING REMISSION IN SYSTEMIC LUPUS ERYTHEMATOSUS | VESENTINI, FILIPPO | |
Scuole di Specializzazione | 2022 | Synovial Markers in Refractory Rheumatoid Arthritis: Distinguishing Non-Inflammatory and Persistent Inflammatory Phenotypes | Synovial Markers in Refractory Rheumatoid Arthritis: Distinguishing Non-Inflammatory and Persistent Inflammatory Phenotypes | SALVATO, MARIANGELA | |
Scuole di Specializzazione | 2022 | Unveiling the Unseen Signals: Identifying Novel Diagnostic and Prognostic Biomarkers for Eosinophilic Granulomatosis with Polyangiitis | Unveiling the Unseen Signals: Identifying Novel Diagnostic and Prognostic Biomarkers for Eosinophilic Granulomatosis with Polyangiitis | IORIO, LUCA |
Mostrati risultati da 1 a 7 di 7
Legenda icone
- file ad accesso aperto
- file ad accesso riservato
- file sotto embargo
- nessun file disponibile